NeoX Biotech
NeoX Biotech combines artificial intelligence with biophysics to advance drug research and development, focusing on macromolecular and multispecific drugs in immuno-oncology.
Services
NeoX Biotech combines artificial intelligence (AI) with biophysics to facilitate drug research and development. Emphasizing the research and development of macromolecular and multispecific drugs, the company particularly focuses on the field of immuno-oncology. NeoX Biotech collaborates with biomedical companies globally, using its advanced platforms to accelerate drug R&D pipelines and enhance early discovery of therapeutics by characterizing protein-protein interactions (PPI).
Research and Development
NeoX Biotech operates at the intersection of AI and biophysics to advance the research and development of macromolecular and multispecific drugs. The company's primary focus is on immuno-oncology, aiming to innovate in this critical therapeutic area. By leveraging AI and a sophisticated platform for analyzing protein-protein interactions (PPI), NeoX Biotech supports the early discovery of novel therapeutics, addressing complex biological processes involved in cancer and other diseases.
Global Collaborations
NeoX Biotech has established cooperation with biomedical companies across the globe to enhance its drug research and development efforts. These collaborations help accelerate drug R&D pipelines, facilitating the rapid advancement of new therapeutic candidates. By partnering internationally, NeoX Biotech integrates diverse expertise and resources, promoting innovation and efficiency in the development of treatments, particularly within the field of immuno-oncology.
Therapeutics Discovery Platform
The company has developed a sophisticated platform dedicated to the early discovery of therapeutics. This platform utilizes AI and biophysics to characterize protein-protein interactions (PPI), which are critical for identifying and validating new drug candidates. By precisely targeting PPIs, NeoX Biotech's platform enhances the efficiency and accuracy of early-stage drug discovery, offering significant potential for developing effective treatments for various diseases.